Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.

Documenti analoghi

• Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
  di: Wu, J H, et al.
  Pubblicazione: (1995)
• The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
  di: Rouy, D, et al.
  Pubblicazione: (1990)
• Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
  di: Weitz, J I, et al.
  Pubblicazione: (1993)
• Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α(2)-antiplasmin
  di: LEE, K. N., et al.
  Pubblicazione: (2011)
• Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.
  di: Runge, M S, et al.
  Pubblicazione: (1987)